IKT

Inhibikase Therapeutics, Inc. $1.55 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.6%
Next 1 week
+1.7%
Next 1 month
+3.4%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 26
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.26%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.45 +3.6% · Seasonal tilt (5y) -0.2%
$1M/day volume 63% volatility +8% 1-year
52-week range · 17% of the way up · -41% from the high
$1.33$2.61

Earnings Full history →

Next report 2026-11-13 (Friday, after close, in 13 days) · EPS est. -0.12.

1-day std dev
5.1%
Finished up
31%
Biggest pop
+7.7%
Biggest drop
-11.6%

Standard deviation of the close-to-close move over the last 13 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-10-27 beat -0.12 -0.11 +12.0% +0.7% +3.3% —
2026-08-11 miss -0.09 -0.11 -17.9% -2.9% -2.0% +0.0%
2026-03-26 beat -0.12 -0.09 +23.9% +1.2% +3.1% +9.8%
2025-11-14 -0.13 -0.13 — -1.3% -0.7% +1.3%
2025-08-14 miss -0.08 -0.11 -37.5% +2.3% +2.3% +10.5%
2025-05-14 miss -0.09 -0.15 -57.9% -2.4% -4.2% -13.2%
2024-11-14 miss -0.48 -0.65 -35.4% +1.7% -2.5% -16.9%
2024-08-14 beat -0.67 -0.66 +1.5% +2.3% -5.4% +5.4%
2024-05-15 beat -0.79 -0.73 +7.6% -8.0% -11.6% -8.0%
2024-03-27 beat -0.85 -0.64 +24.7% -5.2% -6.1% -4.3%
2023-11-14 beat -1.12 -0.86 +23.2% -8.9% -4.1% -6.1%
2023-08-14 miss -0.92 -1.11 -20.6% -1.6% -6.0% -18.1%
2023-05-15 miss -0.90 -0.96 -6.7% +2.6% +7.7% +7.5%

Not investment advice.